Skip to content
Search

Latest Stories

Ravi Teja starrer Khiladi postponed due to the second wave of Covid-19

Ravi Teja starrer Khiladi postponed due to the second wave of Covid-19

By Murtuza Iqbal

The release date of many Telugu films like Tuck Jagadish, Virata Parvam, Love Story, Acharya, and others have been postponed due to the second wave of Covid-19 in India. Now, the makers of Ravi Teja starrer Khiladi have also decided to postpone the release of their film.


The movie was slated to hit the big screens on 28th May 2021.

Ramesh Varma, the director of the film, took to Twitter to inform everyone about it. He tweeted, “Keeping the current #Covid19 Pandemic in mind,Mass Maharaja @RaviTeja_offl 's #Khiladi has been postponed! Game die A New Release Date will be announced soon. @ThisIsDSP @DimpleHayathi @Meenachau6 @sagar_singer @idhavish #AStudiosLLP @PenMovies @KHILADiOffl @adityamusic.”

The teaser of the film was released a few days ago and it had received a good response. Apart from Ravi Teja, the movie also stars Arjun Sarja, Unni Mukundan, Meenakshi Chaudhary, and Dimple Hayathi.

The music of Khiladi is composed by Devi Sri Prasad. He is popularly known as the Rockstar DSP because of his amazing songs.

Talking about Ravi Teja, the actor was last seen on the big screen in Krack which became a blockbuster at the box office. Also starring Shruti Haasan in the lead role, Krack was one of the first big Telugu films to hit the big screens after the pandemic.

Looking at the box office collection of Krack, many filmmakers down South decided to announce the release dates of their movies. Even Bollywood filmmakers got the motivation to release their movies in theatres after a couple of South films did well at the box office.

However, due to the second wave of Covid-19, once again theatres are shut in many states of India, and filmmakers have decided to postpone the release date of their movies.

More For You

Heidi Klum

Heidi and Leni Klum pose together in co-ordinated Intimissimi gowns at the Venice Film Festival

Instagram/heidiklum

Heidi Klum Venice Film Festival look with daughter Leni reignites criticism over mother-daughter lingerie fashion partnership

Highlights:

  • Heidi Klum and daughter Leni walked the Venice Film Festival red carpet in matching corset-style gowns.
  • The supermodel opted for a blush pink silk design, while Leni wore an inky black version.
  • Both gowns were created by Italian lingerie brand Intimissimi, for which they are ambassadors.
  • The mother-daughter duo previously fronted a controversial campaign for the same brand.

Heidi Klum's Venice Film Festival appearances always generate headlines, but this year she doubled the impact by walking the red carpet with her daughter Leni. The pair stunned in co-ordinated gowns from Italian intimates brand Intimissimi, bringing high fashion and red carpet glamour together in one of the festival’s most talked-about moments. Their matching corset silhouettes highlighted the duo’s modelling credentials and added a striking family twist to the opening night of the prestigious event.

Heidi Klum Heidi and Leni Klum pose together in co-ordinated Intimissimi gowns at the Venice Film Festival Instagram/heidiklum

Keep ReadingShow less
Ahaan Panday

Ahaan Panday says years of blind optimism kept him going before Saiyaara

Instagram/ahaanpandayy

Ahaan Panday says Bollywood wronged him and admits he was delusional before 'Saiyaara' broke box office records

Highlights:

  • Ahaan Panday opens up on being ‘wronged’ before his Bollywood debut
  • Actor admits he spent years in ‘blind optimism’ waiting for launch
  • Saiyaara has become the highest-grossing love story in Indian cinema history
  • The Mohit Suri directorial collected £53 million (₹563 crore) worldwide

Bollywood newcomer Ahaan Panday has revealed that he felt “wronged” by people in the industry before finally making his long-awaited debut with Mohit Suri’s Saiyaara. The 27-year-old actor, who comes from the well-known Panday family, said he lived in “blind optimism” for four to five years as projects kept falling through. Despite setbacks, Ahaan maintained that he never became bitter and channelled his struggles into his performance.

Ahaan Panday says years of blind optimism kept him going before Saiyaara Instagram/ahaanpandayy

Keep ReadingShow less
Jio Platforms

Jio Platforms includes India’s largest telecom operator, Reliance Jio Infocomm, with more than 500 million users. (Photo: Reuters)

Reuters

Jio IPO planned for mid-2026, AI unit announced with Meta and Google

RELIANCE Industries plans to take its telecom and digital arm, Jio Platforms, public by mid-2026, chairman Mukesh Ambani said on Friday. The announcement sets a new timeline for the long-awaited IPO of a business analysts value at over $100 billion.

At its annual general meeting (AGM), Reliance also announced the launch of an artificial intelligence unit in partnership with Google and Meta.

Keep ReadingShow less
Sony next console

The top model could match the PS5 Pro at around £699.99

Nintendo

Sony’s next console could be both handheld and dockable, claim rumours

Highlights:

  • Reports suggest Sony is planning three versions of its next console
  • One model, codenamed Canis, could function as both a handheld and a docked console, similar to Nintendo Switch
  • The flagship version, Orion, is expected to be the main high-spec console
  • Pricing speculation indicates the top model could match the PS5 Pro at around £699.99

Fresh rumours claim Sony is preparing a dockable handheld version of its next-generation console, the PlayStation 6. The device, reportedly codenamed Canis, is said to target the same hybrid market as Nintendo’s Switch and the expected Switch 2.

Details of the rumour

The information comes from YouTube channel Moore’s Law is Dead (via Push Square), which suggests Sony will release three versions of the PS6:

Keep ReadingShow less
Mounjaro price rise

Eli Lilly has agreed a discounted supply deal for its weight-loss drug Mounjaro

iStock

Mounjaro’s highest dose to rise from £122 to £247.50, not £330

Highlights:

  • Eli Lilly had announced a steep price rise of up to 170% for Mounjaro.
  • A new discount deal with UK suppliers will limit the increase for patients.
  • Pharmacies will still apply a mark-up, but consumer costs are expected to rise less than initially feared.
  • NHS pricing remains unaffected due to separate arrangements.

Eli Lilly has agreed a discounted supply deal for its weight-loss drug Mounjaro, easing fears of a sharp rise in costs for UK patients. The new arrangement means that, from September, pharmacies and private services will face smaller wholesale increases than first expected, limiting the impact on consumers.

Why the price rise was announced

Earlier this month, Eli Lilly said it would raise Mounjaro’s list price by as much as 170%, which could have pushed the highest monthly dose from £122 to £330. The company argued that UK pricing needed to align more closely with higher costs in Europe and the United States.

Keep ReadingShow less